Field cancerisation of the aerodigestive tract is caused by chronic ex
posure to alcohol and tobacco, but the nature of the genetic alteratio
ns preceding overt malignancy is unknown. To identify potential field
changes we have used a functional assay which tests the transcriptiona
l competence of human p53 expressed in yeast, To increase the sensitiv
ity and reliability of the technique for samples containing under 20%
mutant p53, the 5' and 3'-ends of the p53 cDNA were examined separatel
y. With this split form of the assay the tissue p53 mRNA acts as its o
wn control for RNA quality. Mutations were detected in 87% (46/53) of
tumours, reflecting the high sensitivity of the technique, Multiple bi
opsies of histologically normal tissue from the upper aero-digestive t
ract were tested and clonal p53 mutations were identified in 76% (38/5
0) of biopsies from patients presenting with multiple tumours compared
with 32% (38/117) of biopsies from patients presenting with single tu
mours (P<0.000001). AU patients (16/16) presenting with multiple tumou
rs had at least one positive biopsy, compared with only 53% (19/36) of
patients presenting with single tumours (P<0.001), This defines expan
sion of multiple clones of mutant p53-containing cells as an important
biological mechanism of field cancerisation, and provides a means to
identify patients likely to benefit from intensive screening for the d
evelopment of new head and neck tumours.